Skip to main content
CriticalFDAfda-F-0356-2021UNDECLARED ALLERGEN

Wilton Valentine Chip Crunch Sprinkles, 3.46 oz (98g) clear plastic bottle, SKU 710-4277 UPC 070896042774

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Units Affected
1,638
Recall Date
March 2, 2021
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0356-2021.

Undeclared milk

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0356-2021.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Wilton Industries Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0356-2021.

Wilton Industries Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Wilton Industries Inc Recall FAQ

Wilton Industries Inc is the subject of a snacks & candy safety report: Wilton Valentine Chip Crunch Sprinkles, 3.46 oz (98g) clear plastic bottle, SKU 710-4277 UPC 070896042774. The notice was published on March 2, 2021 by the U.S. Food and Drug Administration (FDA). Approximately 1,638 units are potentially affected.